Simmaron Powers Change in 2015!
2015 marks a powerful turning point for ME/CFS patients, and it’s all happening because of you!
Patients, advocates and researchers have worked tirelessly to elevate our disease at the U.S. National Institutes of Health. On October 29, Dr. Francis Collins, Director of NIH, announced promising changes to the federal research program on ME/CFS, saying “We are going to ramp this up.”

“…it means it’s moved toward the front of the stove.” Dr. Ian Lipkin, Columbia University, Center for Infection & Immunity

Help us continue the Columbia research. Simmaron’s priority is pursuing the next generation of spinal fluid studies with Drs. Ian Lipkin and Mady Hornig, to generate more specific information so we can translate findings into potential diagnostics and treatments.
Phase 2 of the Columbia spinal fluid study is a 2-year project, and we are most of the way through year 1. We need to raise $32,000 to finish funding year 1, and more to fund year 2.
Additionally, given new attention at NIH, now is the time to analyze historical data from one of the field’s most experienced clinicians to catalyze more clinical trials. Simmaron has a unique ability to work with Dr. Daniel Peterson, its Scientific Advisor, to extract data from his rich clinical experience monitoring immune testing and utilizing immune-based treatments. We need your help to make it feasible.
Simmaron is proud to contribute to the rise of ME/CFS science, and we are moved by the knowledge that the more we do now, the sooner the scientific community will fully embrace our disease.
There are more details in Simmaron’s year-end newsletter here. Please remember us on #GivingTuesday, and know that every gift speeds progress.